UCSF Rosenman ADAPT

$400K cash support and connections to healthcare companies for startups developing breakthrough technologies to improve healthcare efficiency. Deadline to apply is October 1, 2021.
Find Out More

Health innovation starts here.

We are an ecosystem of entrepreneurs, industry experts and investors dedicated to improving lives through health technology.
Get in Touch

We empower #healthtech entrepreneurs…

We make getting to market easier for entrepreneurs by offering insider knowledge, mentorship, connections and access to funding.
Get in Touch

…to deliver the future of patient care.

Improving patient lives through innovative technology is our passion and why we do what we do.
Get in Touch

The ecosystem that never sleeps

There’s always a lot of good happening in the Rosenman network — for patients, for entrepreneurs, for investors.
Sep 16, 2021 Showing patients retrospective data has been proven to increase compliance and reduce the need for complex scoliosis surgeries.
Vinod Khosla: Hubris and Paranoia

With Vinod Khosla, Founder, Khosla Ventures

“It’s okay to have overconfidence. It’s okay to do ambitious things, but it’s not okay to be blind to reality.”

Visit the Rosenman Ecosystem Job Board

Companies in our network are growing fast. To succeed, they need to hire the best. If you’re looking for your next career move, check out our latest listings. Want to hire top talent? You’ve come to the right place!

View Our Job Board
Visit the Rosenman Ecosystem Job Board

Watch past event recordings

Collective impact

Helping patients is what drives all of us in the Rosenman community. That takes incredible ideas, access to capital, connections to people who can propel a young brilliant company forward—and an understanding of global regulatory environments.
80522200
Patients Impacted
1093584725
Dollars Raised
36
FDA Approvals

Portfolio

The UCSF Rosenman Institute has been supporting transformative health technology companies from concept to commercialization since 2014.

Testimonials

Here’s what our remarkable Rosenman Innovators and Partners have to say about us
We are delighted to have the opportunity to work with the key healthcare partners through the ADAPT program, and grateful for the impact the $150,000 grant has had on accelerating our technology development. The ADAPT program has supported Emme in our ability to reach patients more quickly and on a broader scale, which is especially meaningful in the context of the unprecedented demand the past year has shown for women’s digital health support.”  

Amanda French
CEO, EMME

Our experience with the Rosenman ADAPT program was exceptional. From the first step (a reasonably short and to the point application, which is rare for opportunities like these), to the periodic updates as we moved through the stages, to the insights and feedback offered during our pitch opportunities, the value for ConsejoSano in working with the Rosenman Institute has been tangible. We’ve already connected with two large potential health plan clients which I expect will lead to significant revenue opportunities for us. I would recommend the ADAPT program to any healthtech company that is ready to grow on a bigger stage.”

Abner Mason
CEO, ConsejoSano

“The Rosenman Innovator program was game-changing for our company. We [met] several highly-experienced mentors whose guidance helped us make drastic changes in our organization and strategy… and optimize our commercial path.”

Ted Abraham, MD
Founder, Perceptive Navigation

“We have always felt so fortunate to have worked with the UCSF Rosenman Institute. Of the three people they introduced us to, one joined as our COO, one as a director of the board and one as a consultant for six months.”

Mehdi Peikar, MD
Founder & CEO, BRIUS

I highly recommend entering the ADAPT Program to any innovative startup! Winning a proof-of-concept opportunity with a leading healthcare company via ADAPT 2020 was a pivotal moment for Oshi Health.  The clinical study we have launched with our sponsor will prove the value of our virtual-first gastroenterology clinic relative to traditional GI care delivery.

Sam Holliday
CEO, Oshi Health

“The Rosenman Innovator program was a fantastic experience and opportunity to get exposure to seed-stage healthcare investors and other industry stakeholders. We met two investors who participated in our round through the program.”

Ade Adesanya
Co-Founder & President, Moving Analytics

“The Rosenman Executive Mentorship program introduced us to medtech legends with years of experience, who have created several hundred million dollars in acquisition value in our technology sector.”

Maryam Parviz
Co-Founder & CEO, SDIP Innovations

“We were matched with Cannon Quality Group, who provided valuable guidance on appropriate quality systems for our stage of development, as well as a roadmap for the future.”

James Mitchell, MD
CEO, Oncodisc

Connect with Rosenman

Science plus social makes for an extra strong network. Join in and join us on social media.

Featured portfolio companies

Check out and connect with these Rosenman portfolio companies.

BRIUS

BRIUS® is a revolutionary method that can be used instead of braces or aligners that moves the teeth independently. Placed behind the teeth so they cannot be seen, this method considerably shortens treatment time, allows for easier cleaning than traditional braces, and is more comfortable than any other behind-the-teeth braces.

 

Learn more

EMME

EMME is a digital health company with a mission to put women’s health in women’s hands.

First up – we’re ushering in a new wave of birth control – coming soon.

Learn more

Zeto

For hospitals and clinics dissatisfied with traditional EEG, Zeto offers a turnkey solution for routine EEG tests. Unlike competitors, Zeto provides lower cost and faster turnaround time to clinics, extraordinary convenience to operators and a better experience to patients. Zeto makes EEG available to facilities that do not have access to trained EEG operators or neurologists.

Learn more